Oxaliplatin As Adjuvant Therapy for Colon Cancer: Updated Results of NSABP C-07 Trial, Including Survival and Subset Analyses

PURPOSE: The National Surgical Adjuvant Breast and Bowel Project (NSABP) C-07 trial demonstrated that the addition of oxaliplatin to fluorouracil plus leucovorin (FULV) improved disease-free survival (DFS) in patients with stage II or III colon cancer. This analysis is the first publication of overa...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Yothers, Greg, O'Connell, Michael J., Allegra, Carmen J., Kuebler, J. Philip, Colangelo, Linda H., Petrelli, Nicholas J., Wolmark, Norman
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Clinical Oncology 2011
Assuntos:
Original Reports
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3188282/
https://ncbi.nlm.nih.gov/pubmed/21859995
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2011.36.4539
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares